From DCAT Value Chain Insights (VCI)
Packaging Coordinators Inc. (PCI) has named Dr.Tadataka Yamada to its board of directors. Dr. Yamada recently rejoined Frazier Healthcare, a principal owner of PCI, as a venture partner on the life sciences team. Prior to his role with Frazier Healthcare, Dr.Yamada served as chief medical and scientific officer at Takeda Pharmaceuticals in Tokyo as well as serving on the Takeda board of directors. Dr.Yamada has also served as president of the Bill & Melinda Gates Foundation Global Health Program, in addition to having served as chairman of research and development at GlaxoSmithKline, where he also served on the board of directors.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription